ALADDIN Education

The ALADDIN Podcast

Education EN ↓ Odcinki: 11

A whole new world of paediatric cancer drug development...The ALADDIN project is a multi-stakeholder educational programme on regulatory science in drug development for children's cancers. Whilst progress has been made to treat children's cancers, there is still a way to go and hope lies in developing new medicines that are more effective and cause less long-term harm. In our brand new podcast, we'll be welcoming a range of guests from the world of paediatric oncology to demystify some of the complex issues that face this specialised field.

Koniecznie odwiedź stronę podcastu i wesprzyj twórcę: aladdin-education.eu

Autor

ALADDIN Education

Kategoria

Education

Strona podcastu

aladdin-education.eu

Ostatni odcinek

20 mar 2025

Gdzie słuchać?

Podcasty w aplikacji Replaio Radio Już wkrótce

Podcasty trafią do aplikacji już wkrótce. Zainstaluj teraz i jako pierwszy zobacz nowe podejście do podcastów

Zainstaluj za darmo Android prawie 10 mln pobrań · ocena 4,7+ iOS niedługo

Odcinki

Dr Ameeta Retzer & Dr Victoria Forster 20.03.2025 45:03

In the 10th episode of the ALADDIN podcast, our host Sara welcomes Dr Ameeta Retzer & Dr Victoria Forster to discuss patient reported outcomes (PROs) and the role of patient engagement in paediatric oncology research.

The role of patient advocates in research 03.02.2025 47:00

In this episode of the ALADDIN podcast, expert advocates Nick Bird, Nicole Scobie and Antonia Palmer share their experiences of engaging in drug development research.

Demystifying academic clinical trials in paediatric oncology 03.12.2024 39:35

In this episode of the ALADDIN podcast, host Sara sits down with Professor of paediatric oncology Pam Kearns, and expert patient advocate Donna Ludwinski to discuss the role of academic clinical trials in developing new medicines for children with cancer.

Prof Michel Zwaan 23.10.2024 36:39

Prof Michel Zwaan is a paediatric oncologist working in the Prinses Maxima Centrum in the Netherlands. In this episode, he discusses the involvement of the pharmaceutical industry in researching new drugs for children with cancer.

Professor Gilles Vassal 16.09.2024 25:09

What is Health Technology Assessment and why is it important for developing new medicines? In this episode of the ALADDIN podcast, Prof. Gilles Vassal gives some insight in preparation for the next public ALADDIN webinar on HTAs. Secure your place at the webinar today: https://portal.aladdin-education.eu/webinar/108

Delphine Heenen & Dr. Davy Chiodin 09.08.2024 33:43

In this episode, Sara chats with Delphine Heenen & Dr. Davy Chiodin about how innovative approaches like repurposing drugs and rescuing shelved drugs can bring solutions in the development of paediatric drugs.

Dr Steve DuBois & Dr Julia Glade-Bender 19.06.2024 40:52

In this episode of the ALADDIN podcast, we talk to paediatric oncologists Dr Steve DuBois and Dr Julia Glade-Bender about the challenges of delivering clinical trials for children with cancer.

Meet the ALADDIN students 23.05.2024 27:23

In this episode, our host Sara chats to some of the students involved in the various ALADDIN activities about their learnings and experience in the programme so far.

Begonya Nafira 10.04.2024 29:22

In this month's episode, our host Sara speaks to patient engagement and involvement expert Begonya Nafira. Begonya is based at the Sant Joan de Déu Hospital in Barcelona, and coordinates their patient engagement programme for children's clinical trials.

Dr Teresa De Rojas 12.03.2024 26:46

In our very first episode, ALADDIN Coordinator Dr Teresa De Rojas gives an overview of the programme and how it has developed so far.

Welcome to the ALADDIN Podcast 16.02.2024 1:49

The brand new ALADDIN podcast is here! Meet our host, Sara Wakeling, and learn more about the new podcast about drug development for children with cancer.